SCHEMBL18132486

SCHEMBL18132486

Clc1nc(-c2ccc(-c3ccccc3)cc2)c2c3ccccc3c3ccccc3c2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ LMNA P02545 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ GLA P06280 1/20 0.50
▸ MAPT P10636 3/20 0.43
▸ DHODH Q02127 4/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ GAA P10253 2/20 0.40
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ OPRK1 P41145 1/20 0.38
▸ PKM P14618 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CYP1A2 P05177 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ NUDT1 P36639 1/20 0.35
▸ TYMS P04818 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18132505 0.97 KDM4E (0.53) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL18132502 0.89 ALDH1A1 (0.42) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL18553595 0.86 ESR1 (0.40) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL18132507 0.83 HTR2B (0.39) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL18666065 0.81 CYP11B1 (0.45) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL22461210 0.81 MEN1 (0.49) ALDH1A1SMN1; SMN2MAPTL3MBTL1GAA
SCHEMBL18553158 0.80 DHODH (0.41) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL18553596 0.77 GPR3 (0.37) KDM4EALDH1A1LMNAHPGDSMN1; SMN2
SCHEMBL18717809 0.76 MEN1 (0.44) KDM4EALDH1A1LMNAHPGDGLA
SCHEMBL19383209 0.76 MAPT (0.35) KDM4EALDH1A1LMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-04-12 — — US disclosed
EP-3135676-A1 ELECTROLUMINESCENT ORGANIC COMPOUNDS FOR ORGANIC ELECTRIC ELEMENTS AND ELECTRONIC DEVICES Duk San Neolux Co., Ltd. (KR) 2017-03-01 — — EP disclosed
WO-2017030307-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS COMPRISING SAME 덕산네오룩스 주식회사 2017-02-23 — — WO disclosed
US-9530971-B1 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2016-12-27 — — US disclosed
US-9530971-B1 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2016-12-27 — — US disclosed
US-9466803-B1 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2016-10-11 — — US disclosed
US-9466803-B1 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2016-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11299459-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, TMEM109 KDM4E 906/4885ALDH1A1 540/4885LMNA 1315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback